BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8236193)

  • 1. [Treatment of menorrhagia with tranexamic acid. A clinical trial of an underestimated problem in general practice].
    Drøsdal H
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2907-10. PubMed ID: 8236193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytics in women with menorrhagia.
    Philipp CS
    Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding.
    Moore KA; Callahan TS; Maison-Blanche P; Morin I; Marenco T; Swearingen D; Olbertz J
    Expert Opin Pharmacother; 2010 Oct; 11(14):2281-90. PubMed ID: 20698724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
    Sundström A; Seaman H; Kieler H; Alfredsson L
    BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
    Lakhani KP; Marsh MS; Purcell W; Hardiman P
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia.
    Preston JT; Cameron IT; Adams EJ; Smith SK
    Br J Obstet Gynaecol; 1995 May; 102(5):401-6. PubMed ID: 7612535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use.
    Phupong V; Sophonsritsuk A; Taneepanichskul S
    Contraception; 2006 Mar; 73(3):253-6. PubMed ID: 16472565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
    Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
    Kouides PA; Byams VR; Philipp CS; Stein SF; Heit JA; Lukes AS; Skerrette NI; Dowling NF; Evatt BL; Miller CH; Owens S; Kulkarni R
    Br J Haematol; 2009 Apr; 145(2):212-20. PubMed ID: 19236375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral modified-release tranexamic acid for heavy menstrual bleeding.
    Hrometz SL
    Ann Pharmacother; 2012; 46(7-8):1047-53. PubMed ID: 22811348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women.
    Lin X; Gao ES; Li D; Zhang M; Dou LX; Yuan W
    Acta Obstet Gynecol Scand; 2007; 86(9):1126-9. PubMed ID: 17712656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hypermenorrhea with tranexamic acid].
    Petersen K; Jelert H; Diernaes E; Detlefsen GU
    Ugeskr Laeger; 1983 Sep; 145(36):2759-60. PubMed ID: 6356545
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding.
    Moore KA; Morin I; Marenco T; Lavigne JR; Morelli G
    Am J Ther; 2012 May; 19(3):190-8. PubMed ID: 21248612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OTC tranexamic acid for heavy menstrual bleeding?
    Drug Ther Bull; 2011 Jan; 49(1):6-8. PubMed ID: 21220253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding.
    Lukes AS; Muse K; Richter HE; Moore KA; Patrick DL
    Curr Med Res Opin; 2010 Nov; 26(11):2673-8. PubMed ID: 20942615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid therapy for heavy menstrual bleeding.
    Lumsden MA; Wedisinghe L
    Expert Opin Pharmacother; 2011 Sep; 12(13):2089-95. PubMed ID: 21767224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.
    Lukes AS; Moore KA; Muse KN; Gersten JK; Hecht BR; Edlund M; Richter HE; Eder SE; Attia GR; Patrick DL; Rubin A; Shangold GA
    Obstet Gynecol; 2010 Oct; 116(4):865-875. PubMed ID: 20859150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.
    Freeman EW; Lukes A; VanDrie D; Mabey RG; Gersten J; Adomako TL
    Am J Obstet Gynecol; 2011 Oct; 205(4):319.e1-7. PubMed ID: 21777897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.